跳至主要内容
临床试验/NL-OMON41523
NL-OMON41523已完成不适用

Withdrawal of antiepileptic drugs in low grade and anaplastic glioma patients after long-term seizure freedom - Withdrawal of AEDs in glioma patients

Vrije Universiteit Medisch Centrum0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • (1) adults (>18 years)
  • (2) histologically confirmed LGG or anaplastic glioma (WHO grade I pilocytic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and subependymoma; WHO grade II astrocytoma , mixed oligo-astrocytoma, oligodendroglioma; ependymoma; WHO grade III brain tumours (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligo-astrocytoma or anaplastic ependymoma))
  • (3) presence of epilepsy and treatment with AEDs
  • (4) past anti-tumour treatment (surgical resection, brain irradiation or temozolomide chemotherapy)
  • (5) stable disease with absence of clinical or radiological signs of tumour recurrence during the past year
  • (6) seizure freedom for at least 1 year counted from the date of first surgery, last day of first irradiation or last day of first temozolomide chemotherapy cycle; OR seizure freedom for at least 2 years from the last non-acute symptomatic post-therapy seizure.

排除标准

  • Patients who underwent biopsy only.

研究者

相似试验